ZOLEDRONAT Osteo Labatec sol perf 5 mg/100ml
7680622570025
CH-62257
M05BA08
07.99.0.
Reimbursement limitations:
ACLASTA3
Pour le traitement de l'ostéoporose documentée, de l'ostéoporose cortico-induite et de la maladie de Paget.
1 / 3
google
Details
- Product number
- 6225701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- acidum zoledronicum 5 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile ad solutionem pro 100 ml corresp., natrium 7.21 mg.
Articles (1)
Zoledronat OSTEO Labatec, solution pour perfusion
Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.21 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 220.65
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/01/2023
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 62257
- Drug name
- Zoledronat OSTEO Labatec, solution pour perfusion
- Galenic form
- LSMP
- ATC Code
- M05BA08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/03/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZOLEDRONAT Osteo Labatec sol perf 5 mg/100ml
- Description (DE)
- ZOLEDRONAT Osteo Labatec Inf Lös 5 mg/100ml
- Market launch
- 29/03/2012
- Narcotic (BTM)
- No